Cargando…

Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy

Simplifying or switching antiretroviral therapy (ART) in treatment-experienced people living with HIV (PLWH) may improve adherence, tolerability, toxicities, and/or drug–drug interactions. The purpose of this review is to critically evaluate the literature for efficacy and safety associated with swi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chastain, Daniel, Badowski, Melissa, Huesgen, Emily, Pandit, Neha Sheth, Pallotta, Andrea, Michienzi, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900586/ https://www.ncbi.nlm.nih.gov/pubmed/31516088 http://dx.doi.org/10.1177/2325958219867325

Ejemplares similares

Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients
por: Schafer, Jason J, et al.
Publicado: (2020)

1044. The Incidence and Severity of Drug interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
por: Schafer, Jason J, et al.
Publicado: (2020)

Evidence Regarding Rapid Initiation of Antiretroviral Therapy in Patients Living with HIV
por: Michienzi, Sarah M., et al.
Publicado: (2021)

Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
por: Brizzi, Marisa, et al.
Publicado: (2023)

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients
por: Fabbiani, M, et al.
Publicado: (2012)

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021)

Two’s a Company, Three’s a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1
por: Badowski, Melissa, et al.
Publicado: (2020)

1309. Effects of a Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Service in Persons Living with HIV/AIDS
por: Brizzi, Marisa B, et al.
Publicado: (2019)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
por: Drwiega, Emily N., et al.
Publicado: (2022)

2502. Impact of Pharmacist-Led Antiretroviral Therapy Simplification Initiative in Heavily Treatment-Experienced Patients on Virologic Control
por: Jimenez, Humberto R, et al.
Publicado: (2019)

Pro-viral DNA and antiretroviral treatment simplification
por: Zucman, D, et al.
Publicado: (2010)

1532. Guideline Adherence to Hepatitis B Virus (HBV) Screening and Vaccination in Patients Prescribed Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis (PrEP)
por: Awad, Reham S, et al.
Publicado: (2023)

2251. Comparing Statin Prescribing Rates in Eligible HIV vs. Non-HIV-Infected Patients
por: Blackman, Alison, et al.
Publicado: (2018)

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
por: Restelli, Umberto, et al.
Publicado: (2014)

939. Immunity to Hepatitis A and/or Hepatitis B Viruses Among Inmates Living with HIV
por: Poondi, Nivedha, et al.
Publicado: (2020)

A Call to Action: The Role of Antiretroviral Stewardship in Inpatient Practice, a Joint Policy Paper of the Infectious Diseases Society of America, HIV Medicine Association, and American Academy of HIV Medicine
por: Koren, David E, et al.
Publicado: (2020)

Antiretroviral Stewardship: A Review of Published Outcomes with Recommendations for Program Implementation
por: Michienzi, Sarah M., et al.
Publicado: (2020)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
por: Portilla, Joaquín, et al.
Publicado: (2014)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

Evidence-based review of statin use in patients with HIV on antiretroviral therapy
por: Chastain, Daniel B., et al.
Publicado: (2017)

1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
por: Ladak, Amber, et al.
Publicado: (2020)

The management of treatment-experienced HIV patients (including virologic failure and switches)
por: Cutrell, James, et al.
Publicado: (2020)

941. Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
por: Michienzi, Sarah M, et al.
Publicado: (2020)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

Changes in functional connectivity in people with HIV switching antiretroviral therapy
por: Toniolo, Sofia, et al.
Publicado: (2020)

Evaluation of treatment simplification strategies in patients living with HIV with multi-drug resistance
por: Harris, Taylor N., et al.
Publicado: (2023)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study
por: Latini, Alessandra, et al.
Publicado: (2016)

Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)
por: Pérez, L, et al.
Publicado: (2010)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

Switching to dual therapy with darunavir/ritonavir and etravirine: a simplification strategy
por: Tyrer, M, et al.
Publicado: (2010)

Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
por: Chiampas, Thomas D., et al.
Publicado: (2019)

Self-initiation of antiretroviral therapy in the developing world: the involvement of private pharmacies in an HIV program
por: Minzi, Omary Mashiku, et al.
Publicado: (2012)

A Qualitative Study Examining HIV Antiretroviral Adherence Counseling and Support in Community Pharmacies
por: Cocohoba, Jennifer, et al.
Publicado: (2013)

Opinions of a Small Sample of Pharmacists About Pharmacy Setting and Patient Adherence to Antiretroviral Therapy
por: Kibicho, Jennifer, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_77jbms8rsntl1f8231h2k96fto